U.S. Oil and Gas Stock News

Oruka Therapeutics (ORKA) stock is catching investor attention after the company shared promising Phase 1 results for ORKA-001, suggesting the potential for annual dosing in psoriasis and longer remission. The completion of new financing also strengthens its balance sheet for upcoming trials. See our latest analysis for Oruka Therapeutics. Momentum in Oruka Therapeutics stock has clearly accelerated as fresh trial data and new financing caught investors’ attention. The share price is up an...

Cigna Group (CI) shares have moved recently, inviting fresh interest from investors reviewing the company’s latest performance metrics. The stock is showing a nearly 10% pullback over the past month, which has shifted attention to its current valuation. See our latest analysis for Cigna Group. While Cigna Group’s share price has slid nearly 10% over the past month, this drop follows several quarters of steady gains and an earlier run of upbeat sentiment. Although momentum has cooled recently,...

Pagaya Technologies (NasdaqCM:PGY) shares came into focus after the company posted a noticeable turnaround in its third quarter, including higher revenue and net income year over year. The company also raised its outlook for the rest of 2025, signaling confidence in ongoing growth. See our latest analysis for Pagaya Technologies. Peppered with upgraded forecasts and a sharp swing into profitability, Pagaya Technologies has captured investor attention despite some recent volatility. While the...

In a recent decision, the Oklahoma Corporation Commission denied OG&E’s request to recover Construction Work in Progress (CWIP) costs from customers for new gas-powered units at the Horseshoe Lake Power Plant, while still approving the construction and related capacity agreements. This regulatory outcome means OG&E must proceed with its new project without passing upfront financing expenses to customers, adding potential challenges for cost recovery and financial planning. We'll assess how...

Innoviva (INVA) grabbed attention after reporting a jump in both revenue and net income for the third quarter. The company also announced a $125 million share repurchase program that could impact shareholder value moving forward. See our latest analysis for Innoviva. Shares of Innoviva have shown renewed momentum lately, with a 28.8% 1-month share price return and the stock now trading at $22.25. This surge follows not only the strong earnings and fresh buyback announcement but also builds on...

Brink's (NYSE:BCO) is drawing attention after posting stronger third quarter sales and net income. The company also unveiled new revenue guidance and highlighted ongoing share repurchases and strategic acquisition plans. Investors are watching for long-term compounding potential. See our latest analysis for Brink's. Brink's shares have steadily gained momentum this year, with a year-to-date share price return of 20.6% and a 1-year total shareholder return of 23.3%. This upward trajectory has...

Walt Disney (DIS) shares have been under pressure lately, with the stock declining over the past month and past 3 months. Investors are weighing company fundamentals, recent performance, and broader market sentiment for clues on what is next. See our latest analysis for Walt Disney. Walt Disney’s share price has been slipping, with a 5.74% decline over the past week alone, adding to a 9% slide in the past three months. Despite moments of renewed optimism tied to its studio releases and...

Earlier this year, several law firms announced class action lawsuits against Marex Group plc after a research report accused the company of engaging in a multi-year accounting scheme involving off-balance-sheet entities and misleading financial disclosures, sparking regulatory and investor scrutiny. Despite reporting an increase in net income to US$222.4 million for the first nine months of 2025 and affirming its quarterly dividend, Marex now faces heightened governance, financial, and legal...

Vaxcyte, Inc. recently reported its third quarter and nine-month 2025 earnings, revealing a net loss of US$212.83 million for the quarter and US$520.12 million for the year to date, both considerably higher than the previous year’s losses. The increased loss per share may draw attention to the company’s spending pace as it continues to invest in pipeline and development activities. We'll examine how Vaxcyte's wider quarterly loss shapes investor perspectives on its path to future...

Sabine Royalty Trust (SBR) just reported a jump in quarterly revenue and net income from a year ago, signaling improved performance. Alongside these results, management also announced new oil and gas production numbers as well as a fresh cash distribution. See our latest analysis for Sabine Royalty Trust. The recent uptick in Sabine Royalty Trust’s share price, now at $79.07, reflects growing investor confidence after a wave of positive updates. Not only has the company posted stronger...

Welltower (WELL) shares have seen impressive momentum in recent weeks, as investors weigh the company’s double-digit annual revenue and net income growth. This uptick comes as renewed interest grows in healthcare-focused real estate strategies. See our latest analysis for Welltower. Welltower’s share price has surged more than 10% over the past month and is up an impressive 55% year-to-date, signaling renewed optimism among investors. With a remarkable 43.95% total shareholder return over the...

Curious if Warner Bros. Discovery is still a value play, or if the market is already onto its next blockbuster? Let's dig into where the stock might stand now. Shares have soared recently, climbing 26.6% over the last month and an eye-popping 143.2% in the past year. This signals renewed confidence and big expectations. Media headlines have spotlighted Warner Bros. Discovery's major streaming deals and content partnerships, painting a picture of a company making big moves in both digital and...

Universal Display Corporation recently announced its third quarter 2025 financial results, reporting revenue of US$139.61 million and net income of US$44.03 million, both lower than the same quarter last year, along with a revision to the lower end of its full-year revenue guidance. An important consideration is that management attributed the softer performance to customer order timing, macroeconomic uncertainty, and an out-of-period royalty and license fee adjustment impacting this...

UFP Industries (UFPI) is drawing attention after its Edge division’s EvoTrim product was recognized with a Good Housekeeping 2026 Home Reno Award. This recognition highlights EvoTrim’s design focus on durability and innovation in exterior building materials. See our latest analysis for UFP Industries. Even with strong moves like the EvoTrim award win, UFP Industries’ momentum has cooled lately, as seen in its 1-year total shareholder return of -29.07%. However, long-term holders have still...

Shares of Alibaba Group Holding (NYSE:BABA) came under pressure after a White House national security memo alleged the company provided the Chinese government, including the military, access to customer data and AI-related services. The company has strongly denied these claims, but the controversy has prompted heightened scrutiny and has weighed on investor sentiment this week. See our latest analysis for Alibaba Group Holding. Just as Alibaba was generating buzz for its bold AI revamp and...

Ormat Technologies (ORA) just lifted its revenue guidance for 2025, projecting total revenues to tally between $960 million and $980 million. This update comes as the company reports solid gains in quarterly sales and net income. See our latest analysis for Ormat Technologies. Ormat’s upbeat 2025 revenue guidance and a fresh quarterly dividend have given investors new reasons to pay attention, and the momentum is showing in the numbers. Its 57% year-to-date share price return stands out, with...

eXp World Holdings (EXPI) reported a return to profitability in the third quarter, reversing last year’s loss. Sales rose, and management pointed to ongoing international expansion, a growing agent network, and new technology initiatives. See our latest analysis for eXp World Holdings. Amid consecutive quarters of agent growth and expanding international reach, eXp World Holdings kept investors engaged with fresh earnings momentum, a newly declared dividend, and continued share buybacks...

Earlier this month, Clavister announced that Arrow Electronics expanded its distribution of Clavister’s full cybersecurity portfolio beyond Sweden into 11 additional European countries, including Belgium, the Netherlands, and Poland. This expansion leverages Arrow’s pan-European logistics and partner relationships, significantly broadening both companies’ reach and strengthening their presence in the cybersecurity market across Northern and Eastern Europe. We'll now consider how Arrow's...

General Mills (GIS) finds itself in the spotlight after a string of headwinds, including flat sales in its North America retail division, fallout from rising costs, and conservative expectations for the upcoming year. Investors are watching how the company will respond amid ongoing industry changes and tighter competition. See our latest analysis for General Mills. The past year has been rough for General Mills shareholders, with the stock’s total return falling over 21%. Despite recent...

Invitation Homes (INVH) held its Analyst and Investor Day at a time when several analysts pulled back on their outlook, keeping ratings steady but lowering expectations. The event provided updates on strategy and operations, but persistent housing market headwinds still cloud the near-term view. See our latest analysis for Invitation Homes. Invitation Homes' latest share price sits at $28.39. While the stock has shown a bumpy ride this year, pressure from the broader housing market has...

monday.com released its third quarter 2025 results, reporting sales of US$316.86 million and turning a net profit of US$13.05 million, compared to a net loss a year earlier. While revenue growth and profitability were strong, the company's guidance for fourth quarter revenue came in below analyst forecasts, raising concerns about market conditions and future momentum. We'll consider how monday.com's cautious fourth quarter revenue outlook shapes its investment narrative and future growth...

UBiqube has expanded its SASE OpsLabs enablement portal to integrate with Netskope (NTSK), rolling out automation kits designed to simplify secure network deployments and migrations for large enterprises. This integration is intended to streamline adoption and reduce manual workloads. See our latest analysis for Netskope. After last week’s announcement of UBiqube’s integration, there has been heightened attention on Netskope, though its shares have not reversed the negative momentum...

On November 5, 2025, RenaissanceRe Holdings announced a share repurchase program authorizing up to US$750 million in buybacks, alongside affirming its quarterly dividend of US$0.40 per share to be paid on December 31, 2025. This combination of direct capital return through buybacks and sustained dividend payments often signals management confidence in operational performance and a focus on shareholder value. Now, we'll explore how the sizeable buyback authorization could influence...

Royalty Pharma reported third quarter 2025 revenue of US$609.29 million, an increase from a year earlier, and raised its full-year Portfolio Receipts guidance to a range of US$3.20 billion to US$3.25 billion. This guidance revision comes alongside an ongoing share repurchase program and follows a period where the company's long-term growth and profitability have been questioned by the market. We’ll examine how Royalty Pharma’s upgraded 2025 revenue guidance could influence its investment...